Q1 2025 Holdings
Filed 2025-05-15 | 116 holdings | $434.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $24.2M | 1,572,181 | 5.6% |
| Ishares TR(TLT)Call | 20 YR TR BD ETF | 464287432 | $23.2M | 255,100 | 5.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $20.4M | 1,663,974 | 4.7% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $16.9M | 304,515 | 3.9% |
| Nova LTD(NVMI) | COM | M7516K103 | $16.7M | 90,697 | 3.8% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $12.9M | 175,060 | 3.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $12.7M | 366,608 | 2.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $10.1M | 157,931 | 2.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $9.7M | 267,385 | 2.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $9.7M | 11,690 | 2.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $9.2M | 507,829 | 2.1% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $8.8M | 52,831 | 2.0% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $8.2M | 118,080 | 1.9% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $7.8M | 2,307,119 | 1.8% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $7.4M | 465,526 | 1.7% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $7.0M | 36,607 | 1.6% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $6.3M | 30,256 | 1.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $6.0M | 383,856 | 1.4% |
| Ormat Technologies Inc(ORA) | COM | 686688102 | $5.9M | 84,000 | 1.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $5.8M | 144,961 | 1.3% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $5.7M | 9,962 | 1.3% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $5.6M | 50,000 | 1.3% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $5.3M | 59,600 | 1.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $5.3M | 140,660 | 1.2% |
| Ormat Technologies Inc | DEBT 2.500% 7/1 | 686688AC6 | $5.2M | 5,037,000 | 1.2% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $5.1M | 33,303 | 1.2% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $5.0M | 130,000 | 1.2% |
| Solaredge Technologies Inc(SEDG) | COM | 83417M104 | $5.0M | 309,216 | 1.2% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $4.5M | 618,343 | 1.0% |
| Merus N V | COM | N5749R100 | $4.5M | 106,532 | 1.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $4.2M | 921,111 | 1.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $4.0M | 181,346 | 0.9% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $3.9M | 355,554 | 0.9% |
| Praxis Precision Medicines I(PRAX)Call | COM NEW | 74006W207 | $3.8M | 100,000 | 0.9% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $3.6M | 200,000 | 0.8% |
| Savara Inc(SVRA) | COM | 805111101 | $3.6M | 1,284,151 | 0.8% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $3.5M | 277,550 | 0.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $3.4M | 329,262 | 0.8% |
| Annexon Inc(ANNX) | COM | 03589W102 | $3.4M | 1,764,387 | 0.8% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $3.4M | 125,840 | 0.8% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $3.3M | 527,222 | 0.8% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $3.3M | 194,638 | 0.8% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $3.2M | 29,605 | 0.7% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $3.1M | 1,081,447 | 0.7% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $3.1M | 106,000 | 0.7% |
| Amgen Inc(AMGN) | COM | 031162100 | $3.1M | 10,000 | 0.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $3.1M | 22,738 | 0.7% |
| Alpha Cognition Inc(ACOG) | COM NEW | 02074J501 | $3.0M | 596,992 | 0.7% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $2.9M | 1,604,429 | 0.7% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $2.7M | 381,080 | 0.6% |